RSC Group: University of Ottawa Joined a Multi-National Team to Combat COVID-19

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

The Bioanalytical and Molecular Interaction Laboratory lead by Professor Maxim Berezovski at the University of Ottawa has joined an international science group “ from Russia, Finland and Italy “ which got high priority access to Russian RSC Tornado supercomputer for studying methods to fight against the COVID-19 coronavirus infection.

The multi-national research team uses a recently upgraded cluster system based on 2nd Generation Intel Xeon Scalable processors, which has been deployed by RSC Group, the leading Russian solution provider for high-performance computing.

The international project aims to develop medicine for diagnostics and therapy against the coronavirus contagious disease that became the cause of the global pandemic. Finding treatments to prevent and mitigate the negative impact of COVID-19 is the highest priority in the worldwide scientific community now. The international and multidisciplinary project takes advantages of the latest advances in experimental physics, chemistry, and biology to investigate the life cycle of the virus and to target specifically its specific proteins. Sophisticated simulation methods require supercomputing power to study all details of the interaction between the Spike-protein on coronavirus surface and the human protein ACE2 which is known to be the entry point for SARS and SARS-2 coronaviruses. It will help to complete all research stages within a limited amount of time.

Rapid global spread of COVID-19 coronavirus infection pandemic has shown that there are no clear global emergency response plans against threats to humankind caused by new viruses. One of the obvious shortcomings is the lack of technologies for the quick development of medicines for diagnostics and therapy. We all have different competencies, knowledge, skills and resources. Our geographically distributed team includes virologists, biologists, chemists, mathematicians and physical scientists. The international cooperation is extremely important to achieve quick progress and rapidly react to the ever-changing situation with global coronavirus pandemic. We hope that our research will actually help to fight the spread of such infections, explains Anna Kichkailo, Head of Laboratory for Digital Controlled Drugs and Theranostics at the Krasnoyarsk Federal Science Center of Russian Academy of Sciences.

The international team consists of:

  • Laboratory for Digital Controlled Drugs and Theranostics and Laboratory of Physics of Magnetic Phenomena, Kirensky Institute of Physics at the Federal Science Center, Siberian Branch of Russian Academy of Sciences (KIP FSC SB RAS, Krasnoyarsk, Russia),
  • Laboratory for Biomolecular and Medical Technology, V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University (KSMU, Krasnoyarsk, Russia) “ project coordinator,
  • Laboratory of Chemical Cybernetics, Department of Chemistry at Lomonosov Moscow State University (MSU, Moscow, Russia),
  • Laboratory for Computer Simulation of Biomolecular Systems and Nanomaterials at N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences (IBCP RAS, Moscow, Russia),
  • Organic Synthesis Laboratory, Institute of Chemical Biology and Fundamental Medical Science, Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS, Novosibirsk, Russia),
  • The Bioanalytical and Molecular Interaction Laboratory, Department of Chemistry and Biomolecular Sciences, University of Ottawa (Canada),
  • Nanoscience Center and Department of Chemistry, University of Jyv¤skyl¤, Jyv¤skyl¤ (Finland),
  • Institute for Experimental Endocrinology and Oncology (IEOS), part of National Research Council (CNR), Naples (Italy),
  • Department of Molecular Medicine and Medical Biotechnology, Federico II University of Naples (Italy).

Press:

Oleg Gorbachov

Corporate Communications Director, RSC Group

+7 (967) 052-50-85

[email protected]